Skip to main content
. 2016 Feb 1;10(2):BC19–BC21. doi: 10.7860/JCDR/2016/15933.7328

[Table/Fig-3]:

Serum AMH levels in study group-IA (Prechemotherapy) and study group-IB (Postchemotherapy). (HS= Highly Significant)

GROUP AMH (ng/mL)
Study Group (IA) 1.67 ± 0.44
Study Group (IB) 1.03 ± 0.25
p-value <0.001
Significance HS